Atlas Trials

DLBCL Transformed From Indolent Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch DLBCL Transformed From Indolent Lymphoma

RecordFirmDate
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant (NCT01321541)CTI BioPharma2011-04-20

Track DLBCL Transformed From Indolent Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.